|
|
Vincent Keane's Testimony Before Council of the District of Columbia- Rx Drug Benefits for DC's Elderly
Introduction
Good morning Chairman Allen, and members of the Committee on Human Services. My name is Vincent Keane, I am the CEO of Unity Health Care, Inc. (Unity). Under our current contractual relationship with the D.C. Healthcare Alliance (The Alliance), Unity manages and staffs the pharmacies currently funded by the Alliance. These sites are located at: Anacostia Health Center D.C. General Hospital Congress Heights Health Center Hunt Place Health Center Southwest Health Center Upper Cardozo Health Center Walker Jones Health CenterThese
sites provide pharmaceuticals for all eligible patients enrolled in The
Alliance. No patients other than Alliance patients are served through
these pharmacies (i.e. no Medicaid or private insurance prescriptions are filled
there.) These pharmacies are
intended to serve not only Alliance patients within the Unity primary care
network, but also all Alliance patients who are served through the Non-profit
Clinic Consortium (NPCC) Health Centers, private physicians, and those patients
who are discharged from hospitals. Again,
I want to emphasize that Unity’s role in the pharmacy system is to manage and
staff the pharmacies, for which we get an annual fee under the terms of our
Alliance contract. Unity does not
determine eligibility, it does not establish the drug formulary, it does not
purchase or pay for the medications. DOH and The Pharmacy
The medications are purchased and paid for by the Department of Health (DOH) through an arrangement with the Department of Defense (DOD). Unity’s pharmacists working in collaboration with DOH staff, stock the pharmacies with drugs that are pre-approved on the formulary established by a Pharmacy Committee working under the direction of DOH. Unity has installed a computer system that provides connectivity between all sites, confirms eligibility once determined by The Alliance, and is capable of generating the necessary reports required by the Health Care Safety Net Administration (HCSNA). Pharmacy Utilization
There
is little doubt about the importance that quality pharmaceuticals play in the
therapeutic process of all patients, but especially those in The Alliance,
because many within this group are sicker than the population in general.
In the long run, it has been proven that early intervention with the
proper medications can reduce more expensive use of hospitalizations and
emergency rooms. It is my personal
belief, and that of all my medical staff, that increased access to quality
medications improves health outcomes, enhances continuity of care, and
ultimately reduces costs. However,
initial up front cost are high. One
of the most expensive drivers in health care today is the cost of
pharmaceuticals, but like all prevention methods, whether it be in the area of
crime or health care, we aren’t always able to see the long term benefit, in
the short run. As the HCSNA Annual
Report indicates for the first year of services: “one of The
Alliance’s primary goals is increasing prescription access to the
uninsured.” I am proud
that we in Unity as a partner within The Alliance have achieved this in the
first year of operation with roughly an 11% increase over previous utilization
in the PBC system. In the current
year we anticipate utilization to be higher because we have added a pharmacy at
Upper Cardozo Health Center to the system.
This site has only been operational since December 2002 and already we
are seeing a much higher volume of patients and prescriptions dispensed than
anticipated. Pharmacy and the Elderly
The
status of the elderly receiving medications under The Alliance has been
inconsistent at best over the 18 month history of The Alliance.
There have been periods of uncertainty regarding enrollment and
eligibility for Medicare recipients that has contributed significantly to
“gaps in service” for this population.
Because of the manner in which The Alliance contract was structured by
the Control Board, Medicare recipients were deemed ineligible for The Alliance
because they were considered to be an insured class.
However, as we know, Medicare does not cover prescription drugs, and
therefore Medicare recipients unable to pay for expensive medications, and in
some cases requiring multiple prescriptions, are unable to access a very
important therupeutic component for their health and welfare.
This problem was exacerbated by the fact the Medicare recipients prior to
The Alliance, in the PBC system, were able to access these medications without
any limitations on income. The
income criteria and the non-insurance status required for Alliance membership
established by the Control Board, rules out Medicare recipients from access to
pharmaceuticals. However,
through a series of Administrative decisions by DOH personnel, a group of
Medicare recipients approximately 520, were allowed to receive “pharmacy
benefits only” under The Alliance. This
number was drawn from the original list of PBC members who were Medicare
recipients and who subsequently applied for and received membership in The
Alliance. It is not clear how many
of the 520 individuals are actually accessing benefits, and the financial income
of those 520 is unclear, some may be 100% of poverty and below, some could be
100% to 200% and some could be 200% and above.
Their determining characteristic is that all had previously received
pharmacy benefits under the PBC. It
should be noted this is not the universe of Medicare recipients who received
benefits under the PBC, that is closer to 1,500.
This current cadre of Medicare eligibles (about 520) are now eligible for
medications under The Alliance program. This
number does not include the over 65 population whose income enables them to
access medications because they are also Medicaid eligible.
It is estimated that the pharmacy costs for serving this “520 number”
is roughly $400,000 per annum. This
number does not include those who have already become eligible for Medicare
since The Alliance was initiated. The
plan currently underway is to transfer this population over the next four (4)
month period to a D.C. Pharmaceutical Resource Center (DCPRC), whereby they will
be enrolled in a patient assistance program, and thus allow them to access free
medications for chronic illnesses, from major drug companies who offer such
programs. The DCPRC is sponsored by
DOH under a grant from Community Voices, in collaboration with the D.C. Primary
Care Association (DCPCA), and will be operated by the Archdiocesan Health Care
Network of Catholic Charities (AHCN). I
want to take this opportunity to compliment all the individuals and agencies
involved in helping bring the DCPRC into existence, and I believe that it is one
step in the right direction to address the critical needs of seniors on Medicare
who lack pharmacy benefits. The
transition period from Alliance to DCPRC will address such issues as: · Income levels · Continuity of patient care ·
Adequate access to medications during the transition period, i.e. 60/90
day coverage until the DCPRC system takes over The
concept of the DCPRC is not new, many physicians and community clinics have been
utilizing patient assistance programs on behalf of their patients for years.
What is different, is that the laborious paperwork and administrative
screening process, along with knowing the eligibility requirements for each drug
company will be conducted at one central location by the staff of AHCN.
The DCPRC will address some of the needs of our seniors. However,
I must also add a caveat here, I do not believe that a DCPRC type program is a
substitute for a system of care required to address a large population who lack
access to pharmaceuticals. The
DCPRC can serve as an excellent pilot program, and the targeted number is
currently 600 patients. However,
last year alone in the Unity network, we served over 2,200 Medicare only
patients, of which 1,300 were at former PBC sites.
Many of these patients were between 100%-200% of poverty, and even those
above 200% would be heavily burdened to have to pay for the multiple medications
that they require for their illnesses. I
believe that the DCPRC will be most successful if it is not perceived as “the
system of care” for the pharmaceutical needs of our seniors, but if it is a
supplement to a system of care that guarantees care for our most vulnerable
seniors. Provision
of prescription drugs for Medicare patients is a national problem.
The current Federal Budget for F.Y. 2004 attempts to address this issue.
But I must add it is very limited and the only way that patients could
access this benefit is through enrolment in a Medicare Managed Care Program, and
to date the experience of seniors with Medicare Managed Care has been poor at
best. I do not believe we will see
any significant relief to this problem on the Federal level. The
DCPRC, and similar patient assistance programs are a supplement but I don’t
believe they are a solution. There
are risks with the PRC type programs including: · Possibility of disruption in patient care · Lack of access to all necessary drugs for seniors with an emphasis on chronic care drugs only · The “fickleness” of the drug companies in withdrawing certain drugs from their patient assistance programs once a market and a patient/physician loyalty has been developed toward that drug. · The high volume of patients who need such medications could not be served by a PRC system that has limited staff and limited resources. ·
I am concerned about the sustainability of the PRC beyond December 2003
when funding runs out even though I know that DCPCA will work hard to secure
ongoing funds. Absence,
a strong federal commitment to this issue, and given that The Alliance contract
at least is implicit that “Medicare recipients” should not receive any
benefits under The Alliance, I strongly recommend that you, Ms. Allen through
your Committee on Human Services insure the inclusion of targeted resources in
the F.Y. 2004 budget to address this problem.
We in the non-profit community will continue to seek every means possible
to secure medications for this vulnerable population which given the current
state of the economy will increase as more and more Medicare patients come onto
the rolls. But without resources
our efforts are patchwork at best. The
single biggest complaint that I have heard from Unity providers and pharmacists
over the past 18 months of The Alliance operation has been the inconsistency and
inadequacy of access to medications for the Medicare population.
I am here today as much to advocate for my staff that feel their patients
are being compromised through lack of such medications.
They are excited about the possibilities of the DCPRC, but they too would
like to see an additional system of care, adequately funded to address this
issue.
|
|
|